These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 23166636)
1. Polymorphisms in ERCC1 and XPF genes and risk of gastric cancer in an eastern Chinese population. He J; Xu Y; Qiu LX; Li J; Zhou XY; Sun MH; Wang JC; Yang YJ; Jin L; Wei QY; Wang Y PLoS One; 2012; 7(11):e49308. PubMed ID: 23166636 [TBL] [Abstract][Full Text] [Related]
2. Functional Polymorphisms at ERCC1/XPF Genes Confer Neuroblastoma Risk in Chinese Children. Zhuo ZJ; Liu W; Zhang J; Zhu J; Zhang R; Tang J; Yang T; Zou Y; He J; Xia H EBioMedicine; 2018 Apr; 30():113-119. PubMed ID: 29544698 [TBL] [Abstract][Full Text] [Related]
3. Association of DNA repair gene polymorphisms with response to chemotherapy and prognosis of gastric cancer in a Chinese population. Li J; Zuo X; Lv X; Kong F; Xu W; Yang S Tumour Biol; 2014 Aug; 35(8):7569-74. PubMed ID: 24793015 [TBL] [Abstract][Full Text] [Related]
4. Distribution and susceptibility of ERCC1/XPF gene polymorphisms in Han and Uygur women with breast cancer in Xinjiang, China. Li H; Zhou L; Ma J; Zhu Y; Fan J; Li N; Zheng Y; Sha T; Zhai Z; Ma B; Dai Z Cancer Med; 2020 Dec; 9(24):9571-9580. PubMed ID: 33067872 [TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in the XPG gene and risk of gastric cancer in Chinese populations. He J; Qiu LX; Wang MY; Hua RX; Zhang RX; Yu HP; Wang YN; Sun MH; Zhou XY; Yang YJ; Wang JC; Jin L; Wei QY; Li J Hum Genet; 2012 Jul; 131(7):1235-44. PubMed ID: 22371296 [TBL] [Abstract][Full Text] [Related]
6. Influence of ERCC1 and ERCC4 polymorphisms on response to prognosis in gastric cancer treated with FOLFOX-based chemotherapy. Lu ZM; Luo TH; Nie MM; Fang GE; Ma LY; Xue XC; Wei G; Ke CW; Bi JW Tumour Biol; 2014 Apr; 35(4):2941-8. PubMed ID: 24318989 [TBL] [Abstract][Full Text] [Related]
7. ERCC1 gene +262A/C polymorphism associated with risk of gastric cardiac adenocarcinoma in nonsmokers. Zhou RM; Niu CX; Wang N; Chen ZF; Lei SE; Li Y Arch Med Res; 2012 Jan; 43(1):67-74. PubMed ID: 22374244 [TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in the ERCC1 and XPF genes and risk of breast cancer in a Chinese population. Yang Z; Fang X; Pei X; Li H Genet Test Mol Biomarkers; 2013 Sep; 17(9):700-6. PubMed ID: 23909490 [TBL] [Abstract][Full Text] [Related]
9. Tagging single nucleotide polymorphisms in excision repair cross-complementing group 1 (ERCC1) and risk of primary lung cancer in a Chinese population. Ma H; Xu L; Yuan J; Shao M; Hu Z; Wang F; Wang Y; Yuan W; Qian J; Wang Y; Xun P; Liu H; Chen W; Yang L; Jin G; Huo X; Chen F; Shugart YY; Jin L; Wei Q; Wu T; Shen H; Huang W; Lu D Pharmacogenet Genomics; 2007 Jun; 17(6):417-23. PubMed ID: 17502833 [TBL] [Abstract][Full Text] [Related]
10. Association of DNA repair gene polymorphisms with response to chemotherapy and prognosis of gastric cancer. Chen ZH; Wang L; Luo LP Genet Mol Res; 2014 Sep; 13(3):7484-91. PubMed ID: 25222248 [TBL] [Abstract][Full Text] [Related]
11. Genetic variations of mTORC1 genes and risk of gastric cancer in an Eastern Chinese population. He J; Wang MY; Qiu LX; Zhu ML; Shi TY; Zhou XY; Sun MH; Yang YJ; Wang JC; Jin L; Wang YN; Li J; Yu HP; Wei QY Mol Carcinog; 2013 Nov; 52 Suppl 1():E70-9. PubMed ID: 23423739 [TBL] [Abstract][Full Text] [Related]
12. Genetic variation in ERCC1 and XPF genes and breast cancer risk. Pei XH; Yang Z; Lv XQ; Li HX Genet Mol Res; 2014 Mar; 13(1):2259-67. PubMed ID: 24737474 [TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms in nucleotide excision repair pathway influences response to chemotherapy and overall survival in osteosarcoma. Sun Y; Wu Y; Li W; Kong Z; Zou X Int J Clin Exp Pathol; 2015; 8(7):7905-12. PubMed ID: 26339355 [TBL] [Abstract][Full Text] [Related]
14. ERCC1 and ERCC2 variants predict survival in gastric cancer patients. Li Y; Liu Z; Liu H; Wang LE; Tan D; Ajani JA; Wei QY PLoS One; 2013; 8(9):e71994. PubMed ID: 24023723 [TBL] [Abstract][Full Text] [Related]
15. Association of ERCC1 and ERCC2 polymorphisms with colorectal cancer risk in a Chinese population. Ni M; Zhang WZ; Qiu JR; Liu F; Li M; Zhang YJ; Liu Q; Bai J Sci Rep; 2014 Feb; 4():4112. PubMed ID: 24531312 [TBL] [Abstract][Full Text] [Related]
16. Association studies of ERCC1 polymorphisms with lung cancer susceptibility: a systematic review and meta-analysis. Zhu J; Hua RX; Jiang J; Zhao LQ; Sun X; Luan J; Lang Y; Sun Y; Shang K; Peng S; Ma J PLoS One; 2014; 9(5):e97616. PubMed ID: 24841208 [TBL] [Abstract][Full Text] [Related]
17. Genetic variability of DNA repair mechanisms influences chemotherapy outcome of gastric cancer. Yu H; Wu X; Zhang Y; Jin Z; Li G; Zhao H Int J Clin Exp Pathol; 2015; 8(4):4106-12. PubMed ID: 26097599 [TBL] [Abstract][Full Text] [Related]
18. Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer. Xue MH; Li GY; Wu XJ; Zhang CX; Zhang CF; Zhu KX Int J Clin Exp Pathol; 2015; 8(5):5563-9. PubMed ID: 26191265 [TBL] [Abstract][Full Text] [Related]
19. Nucleotide excision repair gene ERCC1 polymorphisms contribute to cancer susceptibility: a meta-analysis. Zhang L; Wang J; Xu L; Zhou J; Guan X; Jiang F; Wu Y; Fan W Mutagenesis; 2012 Jan; 27(1):67-76. PubMed ID: 22002622 [TBL] [Abstract][Full Text] [Related]
20. Influences of ERCC1, ERCC2, XRCC1, GSTP1, GSTT1, and MTHFR polymorphisms on clinical outcomes in gastric cancer patients treated with EOF chemotherapy. Liu R; Zhao X; Liu X; Chen Z; Qiu L; Geng R; Guo W; He G; Yin J; Li J; Zhu X Tumour Biol; 2016 Feb; 37(2):1753-62. PubMed ID: 26314858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]